For more than 25 years, recombinant Mycobacterium bovis BCG has been genetically engineered for use as a vehicle for antigen expression and immunomodulation, typically through introducing or deleting a gene from BCG genome. However, BCG transformation efficacy is still unpredictable, and cloning and expression of sequences from mycobacteria is difficult to predict due to the lack of standardization. To overcome such limitations, we have employed the BioBrick format to construct a toolbox of several mycobacterial parts, including coding sequences, reporter genes, selective markers, promoters, and other regulatory sequences. Additionally, we have developed and characterized BioBrick-compatible episomal vectors that are able to replicate in M. bovis BCG to enable expression of heterologous antigens. The availability of a BCG Biobrick toolbox will enable any coding sequence to be optimally expressed in BCG. We believe that this mycobacterial toolbox represents a standardized and useful kit to enhance the efficacy and use of recombinant BCG.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.tube.2019.07.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Diverse Combinatorial Biosynthesis Strategies for C-H Functionalization of Anthracyclinones.
ACS Synth Biol
May 2024
Department of Pharmaceutical Sciences, College of Pharmacy, Ferris State University, Big Rapids, Michigan 49307, United States.
spp. are "nature's antibiotic factories" that produce valuable bioactive metabolites, such as the cytotoxic anthracycline polyketides. While the anthracyclines have hundreds of natural and chemically synthesized analogues, much of the chemical diversity stems from enzymatic modifications to the saccharide chains and, to a lesser extent, from alterations to the core scaffold.
View Article and Find Full Text PDFConstruction and evaluation of gRNA arrays for multiplex CRISPR-Cas9.
Yeast
January 2023
Department of Molecular and Biomedical Sciences, Jožef Stefan Institute, Ljubljana, Slovenia.
Article Synopsis
- The CRISPR-Cas9 system was used to edit the genome of budding yeast (Saccharomyces cerevisiae) by creating double-strand breaks that repair through homologous recombination, allowing for marker-free changes.
- A multiplex system was developed to target six different marker genes using an array of guide RNAs (gRNAs) expressed from a single plasmid.
- The study demonstrated that five simultaneous genetic perturbations could be introduced in yeast cells, improving the efficiency of gRNA assembly and evaluation compared to previous methods.
A BioBricks Metabolic Engineering Platform for the Biosynthesis of Anthracyclinones in .
ACS Synth Biol
December 2022
Department of Pharmaceutical Sciences, College of Pharmacy, Ferris State University, Big Rapids, Michigan 49307, United States.
Actinomycetes produce a variety of clinically indispensable molecules, such as antineoplastic anthracyclines. However, the actinomycetes are hindered in their further development as genetically engineered hosts for the synthesis of new anthracycline analogues due to their slow growth kinetics associated with their mycelial life cycle and the lack of a comprehensive genetic toolbox for combinatorial biosynthesis. In this report, we tackled both issues via the development of the BIOPOLYMER (BIOBricks POLYketide Metabolic EngineeRing) toolbox: a comprehensive synthetic biology toolbox consisting of engineered strains, promoters, vectors, and biosynthetic genes for the synthesis of anthracyclinones.
View Article and Find Full Text PDFA BioBricks toolbox for metabolic engineering of the tetracenomycin pathway.
Biotechnol J
March 2022
Department of Pharmaceutical Sciences, College of Pharmacy, Ferris State University, Big Rapids, Michigan, USA.
Background/goal/aim: The tetracenomycins are aromatic anticancer polyketides that inhibit peptide translation via binding to the large ribosomal subunit. Here, we expressed the elloramycin biosynthetic gene cluster in the heterologous host Streptomyces coelicolor M1146 to facilitate the downstream production of tetracenomycin analogs.
Main Methods And Major Results: We developed a BioBricks genetic toolbox of genetic parts for substrate precursor engineering in S.
SEVA 3.1: enabling interoperability of DNA assembly among the SEVA, BioBricks and Type IIS restriction enzyme standards.
Microb Biotechnol
November 2020
Laboratory of Systems and Synthetic Biology, Wageningen & Research University, Stippeneng 4, Wageningen, 6708 WE, The Netherlands.
Robust synthetic biology applications rely heavily on the design and assembly of DNA parts with specific functionalities based on engineering principles. However, the assembly standards adopted by different communities vary considerably, thus limiting the interoperability of parts, vectors and methods. We hereby introduce the SEVA 3.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!